DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Serono
Serono
R&D Update Call 2020
Low Discontinuation Rate and Side-Effect Burden After Switching to Cladribine Tablets: Canadian Experience from the Advevatm Patient Support Program
Adding Cetuximab to Paclitaxel and Carboplatin for First-Line
Serono and Amgen Sign License Agreement for Multiple Sclerosis Product
Rationale and Design of Classic-MS Study
Expert Opinion on the Use of Cladribine Tablets in Clinical Practice
Merck Serono the Biopharma Division of Merck
Mitoxantrone in Multiple Sclerosis: 1- MEDLINE and 2- Cochrane Library
Post Hoc Analysis of Efficacy of Cladribine Tablets In
Updated Safety of Cladribine Tablets in the Treatment Of
Single Entity Report Merck Kgaa, Darmstadt, Germany
Treatment Satisfaction in Patients with Highly-Active Relapsing Multiple Sclerosis Treated with Cladribine Tablets: CLARIFY-MS Study Interim Analysis
MAVENCLAD (Cladribine) Tablets, for Oral Use HIV Infection
Fundamental Information About the Group the Merck Group
Annual Report 2014 Delivering Growth
Q1 2014 Roadshow Presentation
EMD Serono Check My Medstm
Merck Kgaa, Darmstadt, Germany – FY 2013 Roadshow Presentation
Top View
ANNUAL REPORT 2018 … Is at the Heart of Every- Thing We Do
Avelumab (Anti-PD-L1)
Transformation on Track
F-Star and Merck Serono to Collaborate in the Discovery and Development of Novel Targeted Biologics
Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Relapsing Multiple Sclerosis During an Open-Label
Merck Serono Co., Ltd
MAVENCLAD Safely and Effectively
Effectiveness of Cladribine Tablets in Patients with Relapsing-Remitting RESULTS
Newron and Merck Serono to Broaden Collaboration on New Therapies for Central Nervous System Diseases
Updated Safety of Cladribine Tablets in the Treatment Of
NDD Pipeline Overview
Final Results from the Registry to Evaluate Novantrone Effects In
[Product Monograph Template
Real-World Experience with Cladribine Tablets in the Msbase Registry